Effect of Local Ketamine Subcutaneous Injection at the Incision Site in Reducing the Postoperative Pain Score after Transabdominal Hysterectomy.
Journal
Anesthesiology research and practice
ISSN: 1687-6962
Titre abrégé: Anesthesiol Res Pract
Pays: United States
ID NLM: 101532982
Informations de publication
Date de publication:
2023
2023
Historique:
received:
18
08
2023
revised:
06
10
2023
accepted:
18
10
2023
medline:
13
11
2023
pubmed:
13
11
2023
entrez:
13
11
2023
Statut:
epublish
Résumé
Pain control after operations is essential in decreasing the patient recovery period and potential morbidity. Prescribing opiates is very effective, but significant side effects accompany them. This study aims to examine the effect of local ketamine infiltration in decreasing pain intensity in patients undergoing transabdominal hysterectomy. In this double-blind, randomized, controlled clinical trial, a total of 92 patients undergoing transabdominal hysterectomy aged 30-60 years were selected and divided into two intervention and control groups randomly. For the intervention group, ketamine was injected subcutaneously into the incision site at a dose of 0.5 mg/kg after the operation. In the control group, 5 mg normal saline was used in the same method. Postoperative pain intensity was measured using the visual analog scale (VAS: 0-10). The pain score and dose of administered opioids were documented at 1, 2, 4, 6, 12, and 24 hours and compared between the two groups. Postoperative pain intensity was significantly lower in the intervention group than in the control group, except for hour 24. The mean amounts of administered opioids were significantly lower in the intervention group at hours 6 and 12, as well as the total amount of used opioids, and no significant side effects were documented. Local ketamine subcutaneous injection in the incisional site is effective and is a safe procedure for reducing pain scores in patients who underwent a transabdominal hysterectomy.
Sections du résumé
Background
UNASSIGNED
Pain control after operations is essential in decreasing the patient recovery period and potential morbidity. Prescribing opiates is very effective, but significant side effects accompany them. This study aims to examine the effect of local ketamine infiltration in decreasing pain intensity in patients undergoing transabdominal hysterectomy.
Methods
UNASSIGNED
In this double-blind, randomized, controlled clinical trial, a total of 92 patients undergoing transabdominal hysterectomy aged 30-60 years were selected and divided into two intervention and control groups randomly. For the intervention group, ketamine was injected subcutaneously into the incision site at a dose of 0.5 mg/kg after the operation. In the control group, 5 mg normal saline was used in the same method. Postoperative pain intensity was measured using the visual analog scale (VAS: 0-10). The pain score and dose of administered opioids were documented at 1, 2, 4, 6, 12, and 24 hours and compared between the two groups.
Results
UNASSIGNED
Postoperative pain intensity was significantly lower in the intervention group than in the control group, except for hour 24. The mean amounts of administered opioids were significantly lower in the intervention group at hours 6 and 12, as well as the total amount of used opioids, and no significant side effects were documented.
Conclusion
UNASSIGNED
Local ketamine subcutaneous injection in the incisional site is effective and is a safe procedure for reducing pain scores in patients who underwent a transabdominal hysterectomy.
Identifiants
pubmed: 37953884
doi: 10.1155/2023/7782847
pmc: PMC10640139
doi:
Types de publication
Journal Article
Langues
eng
Pagination
7782847Informations de copyright
Copyright © 2023 Negar Eftekhar et al.
Déclaration de conflit d'intérêts
The authors declare that they have no conflicts of interest.
Références
Biomed Res Int. 2015;2015:749837
pubmed: 26495312
Rev Esp Anestesiol Reanim. 2002 May;49(5):247-53
pubmed: 12216507
J Pain Res. 2014 Jan 17;7:65-70
pubmed: 24465135
Dent Clin North Am. 2016 Apr;60(2):445-71
pubmed: 27040295
Proc Natl Acad Sci U S A. 2001 Jul 17;98(15):8885-90
pubmed: 11447268
Br J Anaesth. 2008 Jan;100(1):36-41
pubmed: 18042559
Saudi J Anaesth. 2014 Jan;8(1):6-10
pubmed: 24665232
Acta Anaesthesiol Belg. 2006;57(4):373-9
pubmed: 17236639
Anesthesiology. 2000 Oct;93(4):1123-33
pubmed: 11020770
Anesth Analg. 2003 Feb;96(2):475-80, table of contents
pubmed: 12538199
Med Sci (Basel). 2017 May 16;5(2):
pubmed: 29099026
Iran Red Crescent Med J. 2014 Mar;16(3):e15506
pubmed: 24829783
Lancet. 1999 Jun 5;353(9168):1959-64
pubmed: 10371588
Eur J Pain. 2018 May;22(5):951-960
pubmed: 29388288
Anesth Analg. 2000 Jun;90(6):1419-22
pubmed: 10825333
Agri. 2006 Jul;18(3):36-44
pubmed: 17089229
Anesthesiology. 1986 Nov;65(5):492-9
pubmed: 3777478
Can J Anaesth. 2011 Oct;58(10):911-23
pubmed: 21773855
Anesth Analg. 2009 Nov;109(5):1645-50
pubmed: 19843803
Int J Med Sci. 2012;9(5):327-33
pubmed: 22745573
Pain Pract. 2014 Feb;14(2):E76-84
pubmed: 23758753
J Obstet Gynaecol. 2013 Jan;33(1):54-9
pubmed: 23259880
J Neurophysiol. 2003 Oct;90(4):2098-105
pubmed: 12815021
Br J Clin Pharmacol. 2014 Feb;77(2):357-67
pubmed: 23432384
Pain. 2012 Jul;153(7):1390-1396
pubmed: 22445291
J Pain Palliat Care Pharmacother. 2010 Jun;24(2):119-28
pubmed: 20504133
Anesthesiology. 2005 Oct;103(4):813-20
pubmed: 16192774